Results 251 to 260 of about 133,411 (313)

Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness - Eight Southern Hemisphere Countries, March-September 2025. [PDF]

MMWR Morb Mortal Wkly Rep
Russ S, Nogareda F, Regan AK, Benedetti E, Pasinovich M, Voto C, Chilver M, Stocks N, Sullivan SG, Cheng AC, Blyth CC, Hassall J, de Almeida WAF, de Paula Júnior FJ, de Melo Araújo AC, Vergara N, Rodríguez Ferrari PC, Fasce RA, Saavedra C, Penayo E, Gómez S, Domínguez C, Anglemyer A, Wood T, Huang QS, Walaza S, Zwane P, Wolter N, Goñi N, Tairovich J, Silvera E, Couto P, Jara J, Kondor RJ, Azziz-Baumgartner E, Chard AN.   +35 more
europepmc   +1 more source

The clinical and economic value of enhanced influenza vaccines for the elderly in Argentina. [PDF]

Vaccine X
Urueña A, Micone P, Mould-Quevedo J, Saenz C, Delgado M, Montes JL, Giglio N.   +6 more
europepmc   +1 more source

Critical assessment of uncertainty in economic evaluations on influenza vaccines for the elderly population in Spain. [PDF]

BMC Infect Dis
Ortiz-de-Lejarazu Leonardo R, Díez Domingo J, de Miguel ÁG, Martinón Torres F, Margüello ER, López-Belmonte Claver JL, Palomo-Jiménez PI, Farré Avellà JM, Abellán Perpiñán JM.   +8 more
europepmc   +1 more source

Comparison of Codon Optimized and Non-Optimized Influenza HA DNA Vaccines

, 2006
Christopher S. Parker
openalex   +1 more source

COVID-19 Vaccine Timing and Co-Administration with Influenza Vaccines in Canada: A Systematic Review with Comparative Insights from G7 Countries. [PDF]

Vaccines (Basel)
Al Hashimi F, Shuaib SE, Bragazzi NL, Chen S, Wu J.   +4 more
europepmc   +1 more source